leisure time -WSS

leisure time

author：leisure time 2025-09-30 16:24:14 - browse：41

This image provided by Novo Nordisk in January 2023, shows packaging for the company's Wegovy drug. — Novo Nordisk via AP

PHILADELPHIA — Novo Nordisk’s obesity drug Wegovy notably cut the risk of heart attacks in a landmark cardiovascular trial that affirms the treatment offers health benefits beyond weight loss.

The company in August had announced that in this trial, called Select, Wegovy reduced the overall rate of major heart problems — heart attacks, stroke, or cardiovascular-related death — by 20%. That finding, which was the primary outcome the trial set out to study, was stronger than many were expecting and led Novo’s stock to surge.

But details of the study, including risk reductions for each specific heart complication, were not released until Saturday, when they were presented here — before a standing-room only crowd — as the first major session of the American Heart Association conference.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Medicare Advantage proposed rates disappoint insurers

Wikipedia

WSS

4 missing after record

Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

The dental labor crisis is a moment of opportunity

The response to Covid

Hundreds of thousands march in Israel. Former security chiefs beg Netanyahu to halt legal overhaul

To avoid data mishandling cases, universities eye AI and other tools

leisure time

leisure time

hotspot

Guidelines to prevent youth baseball injuries need more muscle

The dental labor crisis is a moment of opportunity

Medical leaders decry Supreme Court decision on affirmative action

Woman found dead after suspected bear encounter near Yellowstone, wildlife officials say

Medical leaders decry Supreme Court decision on affirmative action

Severe heat forecast: Where scorching temperatures will persist over the next week

Peter Hotez and the public health issue of online harassment

Industry veterans launch new biotech VC with $310M

Novavax promises a turnaround & Lilly roils the obesity market

To avoid data mishandling cases, universities eye AI and other tools

entertainment

New requirements coming in 2024 for Americans traveling to Europe

Statins reduce cardiovascular risk in people living with HIV

Robert F. Kennedy is pitching centrism on health, even on abortion

How digital tools helped lower hypertension in marginalized patients

Weekend shootings leave at least 6 dead, 20 others wounded in Chicago

Medicare threatens to cut off funding for HCA's Mission hospital

knowledge

focus

Wikipedia

knowledge